British Journal of Cancer - Table of Contents alert Volume 115 Issue 5

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 115, Issue 5 (505-632) Published online 23 August 2016 In this issue Review Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Letters to the Editor Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top Medical treatment of renal cancer: new horizons Basma Greef and Tim Eisen Br J Cancer 2016 115: 505-516; advance online publication, August 4, 2016; 10.1038/bjc.2016.230 Abstract | Full Text Clinical Studies Top Digital vs screen-film mammography in population-based breast cancer screening: performance indicators and tumour characteristics of screen-detected and interval cancers Linda de Munck, Geertruida H de Bock, Renée Otter, Dick Reiding, Mireille JM Broeders, Pax HB Willemse and Sabine Siesling Br J Cancer 2016 115: 517-524; advance online publication, August 4, 2016; 10.1038/bjc.2016.226 Abstract | Full Text Screening women for cervical cancer carcinoma with a HPV mRNA test: first results from the Venice pilot program Tiziano Maggino, Rocco Sciarrone, Bruno Murer, Maria Rosa Dei Rossi, Chiara Fedato, Michela Maran, Melania Lorio, Marika Soldà, Fiorella Zago, Paolo Giorgi Rossi and Manuel Zorzi Br J Cancer 2016 115: 525-532; advance online publication, August 4, 2016; 10.1038/bjc.2016.216 Abstract | Full Text Symptoms and patient factors associated with longer time to diagnosis for colorectal cancer: results from a prospective cohort study Fiona M Walter, Jon D Emery, Silvia Mendonca, Nicola Hall, Helen C Morris, Katie Mills, Christina Dobson, Clare Bankhead, Margaret Johnson, Gary A Abel, Matthew D Rutter, William Hamilton and Greg P Rubin Br J Cancer 2016 115: 533-541; advance online publication, August 4, 2016; 10.1038/bjc.2016.221 Abstract | Full Text Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study A Sayasneh, L Ferrara, B De Cock, S Saso, M Al-Memar, S Johnson, J Kaijser, J Carvalho, R Husicka, A Smith, C Stalder, M C Blanco, G Ettore, B Van Calster, D Timmerman and T Bourne Br J Cancer 2016 115: 542-548; advance online publication, August 2, 2016; 10.1038/bjc.2016.227 Abstract | Full Text Translational Therapeutics Top Insights into significance of combined inhibition of MEK and m-TOR signalling output in KRAS mutant non-small-cell lung cancer Sophie Broutin, Adam Stewart, Parames Thavasu, Angelo Paci, Jean-Michel Bidart and Udai Banerji Br J Cancer 2016 115: 549-552; advance online publication, July 21, 2016; 10.1038/bjc.2016.220 Abstract | Full Text CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer Holger Bronger, Judith Singer, Claudia Windmüller, Ute Reuning, Daniela Zech, Claire Delbridge, Julia Dorn, Marion Kiechle, Barbara Schmalfeldt, Manfred Schmitt and Stefanie Avril Br J Cancer 2016 115: 553-563; advance online publication, August 4, 2016; 10.1038/bjc.2016.172 Abstract | Full Text Molecular Diagnostics Top Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study Namrata Vijayvergia, Patrick M Boland, Elizabeth Handorf, Karen S Gustafson, Yulan Gong, Harry S Cooper, Fathima Sheriff, Igor Astsaturov, Steven J Cohen and Paul F Engstrom Br J Cancer 2016 115: 564-570; advance online publication, August 2, 2016; 10.1038/bjc.2016.229 Abstract | Full Text Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer J J Irlam-Jones, A Eustace, H Denley, A Choudhury, A L Harris, P J Hoskin and C M L West Br J Cancer 2016 115: 571-578; advance online publication, July 21, 2016; 10.1038/bjc.2016.218 Abstract | Full Text FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women Roosmarijn Luttmer, Lise M A De Strooper, Maaike G Dijkstra, Johannes Berkhof, Peter J F Snijders, Renske D M Steenbergen, Folkert J van Kemenade, Lawrence Rozendaal, Theo J M Helmerhorst, René H M Verheijen, W Abraham ter Harmsel, W Marchien van Baal, Peppino G C M Graziosi, Wim G V Quint, Johan W M Spruijt, Dorenda K E van Dijken, Daniëlle A M Heideman and Chris J L M Meijer Br J Cancer 2016 115: 579-587; advance online publication, July 14, 2016; 10.1038/bjc.2016.200 Abstract | Full Text Epidemiology Top Conisation as a marker of persistent human papilloma virus infection and risk of breast cancer Mette Søgaard, Dora K Farkas, Anne G Ording, Henrik T Sørensen and Deirdre P Cronin-Fenton Br J Cancer 2016 115: 588-591; advance online publication, June 2, 2016; 10.1038/bjc.2016.150 Abstract | Full Text De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage I–III breast cancer Amelia Smith, Laura Murphy, Linda Sharp, Darran O'Connor, William M Gallagher, Kathleen Bennett and Thomas I Barron Br J Cancer 2016 115: 592-598; advance online publication, August 2, 2016; 10.1038/bjc.2016.232 Abstract | Full Text Past cervical intraepithelial neoplasia grade 3, obesity, and earlier menopause are associated with an increased risk of vulval cancer in postmenopausal women Kate Coffey, Kezia Gaitskell, Valerie Beral, Karen Canfell, Jane Green, Gillian Reeves and Isobel Barnes on behalf of the Million Women Study Collaborators Br J Cancer 2016 115: 599-606; advance online publication, June 23, 2016; 10.1038/bjc.2016.165 Abstract | Full Text Menopausal hormone therapy and breast cancer: what is the true size of the increased risk? Michael E Jones, Minouk J Schoemaker, Lauren Wright, Emily McFadden, James Griffin, Dawn Thomas, Jane Hemming, Karen Wright, Alan Ashworth and Anthony J Swerdlow Br J Cancer 2016 115: 607-615; advance online publication, July 28, 2016; 10.1038/bjc.2016.231 Abstract | Full Text The fraction of breast cancer attributable to smoking: The Norwegian women and cancer study 1991–2012 Inger T Gram, Melissa A Little, Eiliv Lund and Tonje Braaten Br J Cancer 2016 115: 616-623; advance online publication, June 9, 2016; 10.1038/bjc.2016.154 Abstract | Full Text Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium Nikhil K Khankari, Harvey J Murff, Chenjie Zeng, Wanqing Wen, Rosalind A Eeles, Douglas F Easton, Zsofia Kote-Jarai, Ali Amin Al Olama, Sara Benlloch, Kenneth Muir, Graham G Giles, Fredrik Wiklund, Henrik Gronberg, Christopher A Haiman, Johanna Schleutker, Børge G Nordestgaard, Ruth C Travis, Jenny L Donovan, Nora Pashayan, Kay-Tee Khaw, Janet L Stanford, William J Blot, Stephen N Thibodeau, Christiane Maier, Adam S Kibel, Cezary Cybulski, Lisa Cannon-Albright, Hermann Brenner, Jong Park, Radka Kaneva, Jyotsna Batra, Manuel R Teixeira, Hardev Pandha, Wei Zheng and the PRACTICAL consortium Br J Cancer 2016 115: 624-631; advance online publication, August 4, 2016; 10.1038/bjc.2016.228 Abstract | Full Text Letters to the Editor Top Comment on ‘an Association of Cancer Physicians’ strategy for improving services and outcomes for cancer patients’ Peter Selby and Johnathan Joffe Br J Cancer 2016 115: e1; advance online publication, July 21, 2016; 10.1038/bjc.2016.168 Full Text Comment on ‘The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study’ Bernard Friedenson Br J Cancer 2016 115: e2; advance online publication, July 26, 2016; 10.1038/bjc.2016.192 Full Text Comment on ‘The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study’ A V Paradiso, M Digennaro and D Sambiasi Br J Cancer 2016 115: e3; advance online publication, July 26, 2016; 10.1038/bjc.2016.224 Full Text Response to ‘Comments on 'The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study’’ Steven A Narod Br J Cancer 2016 115: e4; advance online publication, July 26, 2016; 10.1038/bjc.2016.225 Full Text Comment on: ‘Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade’ Alessandro Cucchetti, Matteo Cescon and Antonio Daniele Pinna Br J Cancer 2016 115: e5; advance online publication, June 23, 2016; 10.1038/bjc.2016.196 Full Text Reply to: Comment on: ‘Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade’ Philip Johnson, Paul BS Lai and Hidenori Toyoda Br J Cancer 2016 115: e6; advance online publication, June 23, 2016; 10.1038/bjc.2016.197 Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.